Research On Financial Risk Of Anke Biological Acquisition Of SOHO-YIMING

Under the background of the rapid development of China's market economy,the main direction of economic development tends to be the adjustment of corporate structure,the integration of industries and the optimization and upgrading of industries,which promotes large-scale mergers and acquisitions among enterprises.Therefore,in this context,enterprises can achieve rapid development and transformation and upgrading mainly through mergers and acquisitions.Among all the industries,the pharmaceutical industry is an emerging industry,because of its high threshold and strong technical characteristics,in order to expand the enterprise scale,closely follow the pulse of the industry,and keep up with the pace of The Times,there is no doubt that mergers and acquisitions is a good way,so in recent years,all mergers and acquisitions of TCM enterprises are relatively frequent.In the process of mergers and acquisitions,pharmaceutical enterprises need to pay more attention to the control of financial risks,because the quality of financial risk control directly affects the effect of mergers and acquisitions of pharmaceutical enterprises.Therefore,in the process of mergers and acquisitions,enterprises should take multiple measures,have accurate analysis of the financial risks that may be brought,better prevention and control,and give play to the synergies after mergers and acquisitions,so as to improve the efficiency of mergers and acquisitions,enhance the competitiveness of enterprises,and lay a solid foundation for the success and benefits of mergers and acquisitions.This paper first summarizes the theoretical basis of financial risks brought by mergers and acquisitions in recent years with the method of literature review,and then expounds the concepts and types of mergers and acquisitions and financial risks,providing theoretical direction for the case analysis in the following paper.Next,the case study of anke biological's merger with suhaoyiming is adopted to comprehensively analyze the possible valuation risk,financing payment risk and financial integration risk in the merger activity.It is concluded that anke avoided financial risks to a certain extent in this merger and acquisition activity,and achieved good synergies,expanded the enterprise scale,increased the sales profit,and improved the competitiveness of the enterprise.Finally,this article is based on bianco biological response in the process of mergers and acquisitions,for example: select the appraisal institutions,valuation methods,the financing channels,late payment and m&a integration gain some enlightenment on the following several aspects: mergers and acquisitions should choose professional appraisal institution,scientific and careful assessment of enterprise value,optimize the structure of corporate financing,taking the appropriate payment,and make the appropriate financial system integration plan.